GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough Currently in phase III clinical development with anticipated regulatory approval and launch in 2026 Accretive to adjusted EPS from 2027 with significant sales potential through 2031 LONDON–(BUSINESS WIRE)–GSK plc (LSE/NYSE: GSK) and … [Read more…]

Advancing Precision Care: GE HealthCare Introduces an Innovative Solution to Help Expand Interventional CT Access

CHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) is further advancing its precision care strategy with CT-Navigation, which offers clinicians detailed, real-time, 3D computed tomography (CT) images for stereotactic needle guidance across an array of care areas, including interventional and oncological procedures as well as biopsies, ablations, drainage, therapeutics and more. Interventional radiology – and specifically interventional CT … [Read more…]

Life Spine Releases Published Article on the Effect of Expandable Versus Static Lordotic Interbody Implants in Minimally Invasive Spine Surgery

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company has published a new retrospective study examining the effect of expandable versus static interbody implants via the Journal of Spine Surgery (JSS). The paper assessed the results of … [Read more…]

Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Recipients Announced

Eighteen Three-Year Grants of $375,000 Each Awarded, for a Total of $6.75 Million RIYADH, Saudi Arabia & NEW YORK–(BUSINESS WIRE)–#agingresearch—Hevolution Foundation and the American Federation for Aging Research (AFAR) are pleased to announce the inaugural Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research recipients. Eighteen three-year awards of $375,000 each, for a total … [Read more…]

PharmaJet Announces U.S. Government Award Expansion to Clinically Assess a DNA Vaccine Combined with its Systems

PharmaJet will clinically assess the effective delivery of a Venezuelan Equine Encephalitis Virus DNA candidate vaccine with either Tropis® or Stratis® in support of the Department of Defense medical countermeasures development activities. Follow-on award under a multi-year agreement with the U.S. Defense Threat Reduction Agency (DTRA) GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company engineering Precision Delivery Systems™ … [Read more…]

Repare Therapeutics Presents Initial Clinical Data from the Phase 1/2 TRESR and ATTACC Trials Evaluating Camonsertib in Combination with Three PARP Inhibitors at the 2023 AACR Annual Meeting

Camonsertib PARPi combinations demonstrated 48% CBR in patients with unmet medical needs, across tumor types, and regardless of PARPi partner or platinum resistance, with a favorable safety and tolerability profile Combination results showed most benefit in late-line ovarian cancer demonstrating 32% overall response, 58% CBR and mPFS of approximately 7 months Early ctDNA molecular responses … [Read more…]

Survey Confirms an Overwhelming Majority of Americans Want the Flexibility to Use Pre-Tax Dollars to Purchase Nutritional Supplements for Better Health

Most people who have flexible spending or health savings accounts think supplements should be covered as “medical expenses” WASHINGTON–(BUSINESS WIRE)–Today, the Council for Responsible Nutrition (CRN) and the Consumer Healthcare Products Association (CHPA) announced the findings of a jointly-commissioned Ipsos survey, which explored people’s understanding of how their flexible spending accounts (FSAs) and health savings … [Read more…]

HealthStream First Quarter 2023 Earnings Conference Call Announcement

NASHVILLE, Tenn.–(BUSINESS WIRE)–HealthStream, Inc. (Nasdaq: HSTM), a leading provider of workforce and provider solutions for the healthcare industry, announced today that it will hold a conference call and webcast to discuss its first quarter 2023 financial results on Tuesday April 25th, 2023. The Company’s financial results for the first quarter, ended March 31, 2023, will … [Read more…]

Fuse Medical, Inc. Fiscal Year 2022 Financial Results

RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its annual report on Form 10-K for the year ended December 31, 2022 with the Securities and Exchange Commission (“SEC”) on April 14, 2023. Fiscal Year 2022 Financial … [Read more…]

Stilla Technologies adds 20 new oncology liquid biopsies kits to its reagents portfolio from partner ApexBio

BURLINGTON, Mass.–(BUSINESS WIRE)–#PCR–Stilla Technologies today announced the availability of 20 new digital PCR assays, optimized for its Crystal Digital PCR™ platform, the naica® system, to be utilized for the detection of circulating tumor DNA (ctDNA) from liquid biopsy samples. Produced by distributor and technology partner ApexBio, these digital PCR kits are designed for the absolute … [Read more…]